191A — MIMOSA Co Income Statement

0.000.00%

Last trade - 00:00

HealthcareHighly SpeculativeMicro Cap

Annual income statement for MIMOSA Co, fiscal year end - March 31st, JPY millions except per share, conversion factor applied.

	2022 March 31st	2023 March 31st	2024 March 31st	2025 March 31st	2026 March 31st
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	PROSPECTUS	PROSPECTUS	Tanshin	Yuho	Tanshin
Standards:	JAS	JAS	JAS	JAS	JAS
Status:	Final	Final	Preliminary	Final	Preliminary
Revenue
Total Revenue	12,761	13,928	14,966	16,344	17,844
Cost of Revenue
Gross Profit	1,322	1,270	1,571	1,374	1,675
Selling / General / Administrative Expenses
Depreciation and Amortization
Unusual Expense / Income
Other Operating Expenses
Total Operating Expenses	12,593	13,878	14,814	16,379	17,771
Operating Profit	168	50.3	152	-35.3	72.8
Total Net Non Operating Interest Income / Expense
Total Net Non Operating Interest Income / Expense
Other Net Non Operating Costs
Net Income Before Taxes	219	221	384	97.8	205
Provision for Income Taxes
Net Income After Taxes	175	152	262	53.3	144
Net Income Before Extraordinary Items
Net Income	175	152	262	53.3	144
Adjustments to Net Income
Income Available to Common Shareholders Excluding Extraordinary Items
Income Available to Common Shareholders Including Extraordinary Items
Diluted Net Income	175	152	262	53.3	144
Diluted Weighted Average Shares
Basic EPS Including Extraordinary Items
Diluted EPS Including Extraordinary Items
Diluted EPS Excluding Extraordinary Items
Normalised Income Before Taxes
Normalised Income After Taxes
Normalised Income Available to Common Shareholders
Diluted Normalised EPS	266	227	386	82.3	360
Dividends per Share